This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (332)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Neurology  • Cognitive Disorders  • Dementias  • Women's Health  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Women's Health Initiative Memory Study

Sally A. Shumaker, PhD; Claudine Legault, PhD; Lewis Kuller, MD, DrPH; Stephen R. Rapp, PhD; Leon Thal, MD; Dorothy S. Lane, MD, MPH; Howard Fillit, MD; Marcia L. Stefanick, PhD; Susan L. Hendrix, DO; Cora E. Lewis, MD; Kamal Masaki, MD; Laura H. Coker, PhD; for the Women's Health Initiative Memory Study

JAMA. 2004;291:2947-2958.

Context  The Women's Health Initiative Memory Study (WHIMS) previously found increased risk for dementia and no effect on mild cognitive impairment (MCI) in women treated with conjugated equine estrogens (CEE) plus medroxyprogesterone acetate (MPA).

Objective  To determine the effects of CEE alone and CEE plus MPA on incidence of probable dementia and MCI in older women.

Design, Setting, and Participants  Randomized, double-blind, placebo-controlled clinical trials of CEE (estrogen-alone trial) or CEE plus MPA (estrogen plus progestin trial) in community-dwelling women aged 65 to 79 years, conducted from June 1995 to July 8, 2002 (estrogen plus progestin; n = 4532), or to February 29, 2004 (estrogen-alone; n = 2947), in 39 of the 40 WHI clinical centers.

Interventions  In the estrogen-alone trial, 1 daily tablet containing either 0.625 mg/d of CEE vs matching placebo; in the estrogen plus progestin trial, 1 daily tablet containing CEE (0.625 mg/d) plus MPA (2.5 mg/d) vs matching placebos.

Main Outcome Measures  Probable dementia and MCI.

Results  In the estrogen-alone trial, 47 participants were diagnosed with probable dementia, of whom 28 were assigned to CEE and 19 to placebo (hazard ratio [HR], 1.49; 95% confidence interval [CI], 0.83-2.66). Incidence rates for probable dementia in the estrogen-alone trial were statistically similar to those in the estrogen plus progestin trial (45 vs 22 per 10 000 person-years for CEE plus MPA vs placebo, respectively; P = .11). When data were pooled per the original WHIMS protocol, the overall HR for probable dementia was 1.76 (95% CI, 1.19-2.60; P = .005). After excluding participants with baseline Modified Mini-Mental State Examination scores at or below the screening cut point, the HR was 1.77 (95% CI, 0.74-4.23; P = .20) in the estrogen-alone trial and 2.19 (95% CI, 1.25-3.84; P = .006) in the pooled trials. In the estrogen-alone trial, 76 participants were diagnosed with MCI in the CEE group vs 58 in the placebo group (HR, 1.34; 95% CI, 0.95-1.89). In the combined trial data, the HR was similar (1.25; 95% CI, 0.97-1.60). In the estrogen-alone trial, 93 participants receiving CEE were diagnosed with either probable dementia or MCI vs 69 receiving placebo (HR, 1.38; 95% CI, 1.01-1.89; P = .04).

Conclusions  Estrogen therapy alone did not reduce dementia or MCI incidence and increased the risk for both end points combined. Pooling data for estrogen alone and estrogen plus progestin resulted in increased risks for both end points. Use of hormone therapy to prevent dementia or cognitive decline in women 65 years of age or older is not recommended.

Author Affiliations: Departments of Public Health Sciences (Drs Shumaker, Legault, and Coker) and Psychiatry and Behavioral Medicine (Dr Rapp), Wake Forest University School of Medicine, Winston-Salem, NC; Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pa (Dr Kuller); Department of Neurosciences, University of California at San Diego (Dr Thal); Department of Preventive Medicine, State University of New York at Stony Brook (Dr Lane); Institute for the Study of Aging, New York, NY (Dr Fillit); Stanford Prevention Research Center, Stanford University, Stanford, Calif (Dr Stefanick); Department of Obstetrics and Gynecology, Wayne State University School of Medicine/Hutzel Hospital, Detroit, Mich (Dr Hendrix); Department of Medicine, University of Alabama at Birmingham (Dr Lewis); Department of Geriatric Medicine, University of Hawaii, Honolulu (Dr Masaki).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women: Women's Health Initiative Memory Study
Mark A. Espeland, Stephen R. Rapp, Sally A. Shumaker, Robert Brunner, JoAnn E. Manson, Barbara B. Sherwin, Judith Hsia, Karen L. Margolis, Patricia E. Hogan, Robert Wallace, Maggie Dailey, Ruth Freeman, Jennifer Hays, and for the Women's Health Initiative Memory Study
JAMA. 2004;291(24):2959-2968.
ABSTRACT | FULL TEXT  

Estrogen and Dementia: Insights From the Women's Health Initiative Memory Study
Lon S. Schneider
JAMA. 2004;291(24):3005-3007.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Brain Volumes, Cognitive Impairment, and Conjugated Equine Estrogens
Espeland et al.
J Gerontol A Biol Sci Med Sci 2009;64A:1243-1250.
ABSTRACT | FULL TEXT  

Characteristics of hormone therapy, cognitive function, and dementia: The prospective 3C Study
Ryan et al.
Neurology 2009;73:1729-1737.
ABSTRACT | FULL TEXT  

Hormone therapy and cognitive function
Maki and Sundermann
Hum Reprod Update 2009;15:667-681.
ABSTRACT | FULL TEXT  

Effects of Conjugated Equine Estrogens on Cognition and Affect in Postmenopausal Women with Prior Hysterectomy
Resnick et al.
J. Clin. Endocrinol. Metab. 2009;94:4152-4161.
ABSTRACT | FULL TEXT  

The Differences in Neuroprotective Efficacy of Progesterone and Medroxyprogesterone Acetate Correlate with Their Effects on Brain-Derived Neurotrophic Factor Expression
Jodhka et al.
Endocrinology 2009;150:3162-3168.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone Treatment
Hulley and Grady
JAMA 2009;301:2493-2495.
FULL TEXT  

New study underlines hormone therapy's beneficial effect on colorectal cancer risk
Brown
Menopause Int 2009;15:5-7.
FULL TEXT  

Menopause, cognitive ageing and dementia: practice implications
Henderson
Menopause Int 2009;15:41-44.
ABSTRACT | FULL TEXT  

A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor {beta}-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo
Zhao et al.
Endocrinology 2009;150:770-783.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and subclinical cerebrovascular disease: The WHIMS-MRI Study
Coker et al.
Neurology 2009;72:125-134.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study
Resnick et al.
Neurology 2009;72:135-142.
ABSTRACT | FULL TEXT  

The Potential for Estrogens in Preventing Alzheimer's Disease.
Simpkins et al.
Therapeutic Advances in Neurological Disorders 2009;2:31-49.
ABSTRACT  

Reassessing Benefits and Risks of Hormone Therapy
Gass et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2009;3:29-43.
ABSTRACT  

Progesterone Influence on Neurite Outgrowth Involves Microglia
Wong et al.
Endocrinology 2009;150:324-332.
ABSTRACT | FULL TEXT  

Dementia Prevention: Methodological Explanations for Inconsistent Results
Coley et al.
Epidemiol Rev 2008;30:35-66.
ABSTRACT | FULL TEXT  

Estrogen and Comprehension of Metaphoric Speech in Women Suffering From Schizophrenia: Results of a Double-Blind, Placebo-Controlled Trial
Bergemann et al.
Schizophr Bull 2008;34:1172-1181.
ABSTRACT | FULL TEXT  

In Vivo Profiling of Estrogen Receptor/Specificity Protein-Dependent Transactivation
Wu et al.
Endocrinology 2008;149:5696-5705.
ABSTRACT | FULL TEXT  

Protein Phosphatase 1, Protein Phosphatase 2A, and Calcineurin Play a Role in Estrogen-Mediated Neuroprotection
Don Yi and Simpkins
Endocrinology 2008;149:5235-5243.
ABSTRACT | FULL TEXT  

Incidence of Dementia in Long-term Hormone Users
Petitti et al.
Am J Epidemiol 2008;167:692-700.
ABSTRACT | FULL TEXT  

Hormone Therapy, Dilemmas, Medical Decisions.
Schulkin
J Law Med Ethics 2008;36:73-88.
 

Estrogen Receptor-Independent Neuroprotection via Protein Phosphatase Preservation and Attenuation of Persistent Extracellular Signal-Regulated Kinase 1/2 Activation
Yi et al.
J. Pharmacol. Exp. Ther. 2008;324:1188-1195.
ABSTRACT | FULL TEXT  

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
Patterson et al.
CMAJ 2008;178:548-556.
ABSTRACT | FULL TEXT  

Medical Management of Frontotemporal Dementia
Caselli and Yaari
AM J ALZHEIMERS DIS OTHER DEMEN 2008;22:489-498.
ABSTRACT  

Persistence of Contradicted Claims in the Literature
Tatsioni et al.
JAMA 2007;298:2517-2526.
ABSTRACT | FULL TEXT  

Antioxidants and Prevention of Cognitive Decline: Does Duration of Use Matter?
Yaffe
Arch Intern Med 2007;167:2167-2168.
FULL TEXT  

Hormone therapy in menopausal women with cognitive complaints: A randomized, double-blind trial
Maki et al.
Neurology 2007;69:1322-1330.
ABSTRACT | FULL TEXT  

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause
Rocca et al.
Neurology 2007;69:1074-1083.
ABSTRACT | FULL TEXT  

The effect of hormone replacement therapy on cognitive function in post-menopausal women
Lavi et al.
QJM 2007;100:567-573.
ABSTRACT | FULL TEXT  

Estrogen Receptors: How Do They Signal and What Are Their Targets
Heldring et al.
Physiol. Rev. 2007;87:905-931.
ABSTRACT | FULL TEXT  

Neurocognitive Outcomes Are Not Improved by 17{beta}-Estradiol in Postmenopausal Women Undergoing Cardiac Surgery
Hogue et al.
Stroke 2007;38:2048-2054.
ABSTRACT | FULL TEXT  

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board
Wittes et al.
Clin Trials 2007;4:218-234.
ABSTRACT  

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
ADAPT Research Group
Neurology 2007;68:1800-1808.
ABSTRACT | FULL TEXT  

Activation of a Membrane-Associated Androgen Receptor Promotes Cell Death in Primary Cortical Astrocytes
Gatson and Singh
Endocrinology 2007;148:2458-2464.
ABSTRACT | FULL TEXT  

Cognitive function and menopausal hormone therapy
Doren
Hum Reprod Update 2007;13:329-329.
FULL TEXT  

Postmenopausal hormone therapy
Grady and Barrett-Connor
BMJ 2007;334:860-861.
FULL TEXT  

Managing the menopause
Roberts
BMJ 2007;334:736-741.
FULL TEXT  

Estrogen, cognition and female ageing
Genazzani et al.
Hum Reprod Update 2007;13:175-187.
ABSTRACT | FULL TEXT  

Selective Activation of Estrogen Receptor-{beta} Transcriptional Pathways by an Herbal Extract
Cvoro et al.
Endocrinology 2007;148:538-547.
ABSTRACT | FULL TEXT  

Brain Infusion of Lipopolysaccharide Increases Uterine Growth as a Function of Estrogen Replacement Regimen: Suppression of Uterine Estrogen Receptor-{alpha} by Constant, But Not Pulsed, Estrogen Replacement
Marriott et al.
Endocrinology 2007;148:232-240.
ABSTRACT | FULL TEXT  

Behavior-Based Interventions to Enhance Cognitive Functioning and Independence in Older Adults
Shumaker et al.
JAMA 2006;296:2852-2854.
FULL TEXT  

Management of Menopausal Symptoms
Grady
NEJM 2006;355:2338-2347.
FULL TEXT  

Primary prevention trials in Alzheimer disease.
Green and DeKosky
Neurology 2006;67:S2-S5.
ABSTRACT | FULL TEXT  

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
Burns and O'Brien
J Psychopharmacol 2006;20:732-755.
ABSTRACT  

Dose and Temporal Pattern of Estrogen Exposure Determines Neuroprotective Outcome in Hippocampal Neurons: Therapeutic Implications
Chen et al.
Endocrinology 2006;147:5303-5313.
ABSTRACT | FULL TEXT  

Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women
Morrison et al.
J. Neurosci. 2006;26:10332-10348.
FULL TEXT  

Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Turgeon et al.
Endocr. Rev. 2006;27:575-605.
ABSTRACT | FULL TEXT  

Estrogen therapy and cognition: A 6-year single-blind follow-up study in postmenopausal women.
Alhola et al.
Neurology 2006;67:706-709.
ABSTRACT | FULL TEXT  

Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
Yaffe et al.
Arch Neurol 2006;63:945-950.
ABSTRACT | FULL TEXT  

Differential Modulation of Estrogen Receptors (ERs) in Ischemic Brain Injury: A Role for ER{alpha} in Estradiol-Mediated Protection against Delayed Cell Death
Dubal et al.
Endocrinology 2006;147:3076-3084.
ABSTRACT | FULL TEXT  

Novel Mechanisms for Estrogen-Induced Neuroprotection.
Singh et al.
Exp. Biol. Med. 2006;231:514-521.
ABSTRACT | FULL TEXT  

Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick et al.
J. Clin. Endocrinol. Metab. 2006;91:1802-1810.
ABSTRACT | FULL TEXT  

Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study
Espeland et al.
Clin Trials 2006;3:99-106.
ABSTRACT  

Multiple primary melanoma: two-year results from a population-based study.
Titus-Ernstoff et al.
Arch Dermatol 2006;142:433-438.
ABSTRACT | FULL TEXT  

Estrogen Alters Spine Number and Morphology in Prefrontal Cortex of Aged Female Rhesus Monkeys
Hao et al.
J. Neurosci. 2006;26:2571-2578.
ABSTRACT | FULL TEXT  

What is the best evidence for determining harms of medical treatment?
Vandenbroucke
CMAJ 2006;174:645-646.
FULL TEXT  

Starting down the right path: nutrition connections with chronic diseases of later life
Dwyer
Am. J. Clin. Nutr. 2006;83:415S-420S.
ABSTRACT | FULL TEXT  

Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
Lu et al.
Arch Neurol 2006;63:177-185.
ABSTRACT | FULL TEXT  

Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement
Rippon et al.
Neurology 2006;66:35-40.
ABSTRACT | FULL TEXT  

Estradiol Replacement Enhances Working Memory in Middle-Aged Rats When Initiated Immediately after Ovariectomy But Not after a Long-Term Period of Ovarian Hormone Deprivation
Daniel et al.
Endocrinology 2006;147:607-614.
ABSTRACT | FULL TEXT  

Update in Women's Health
Crandall and Pregler
ANN INTERN MED 2005;143:823-829.
FULL TEXT  

Predicting Alzheimer's Disease in the Baltimore Longitudinal Study of Aging
Zonderman
J Geriatr Psychiatry Neurol 2005;18:192-195.
ABSTRACT  

Effects of Estrogen and Progrestin on Hypothalamic Blood Flow Autoregulation
Szelke et al.
Reproductive Sciences 2005;12:604-609.
ABSTRACT  

Association of sex steroid hormones with brain morphology and cognition in healthy elderly men
Lessov-Schlaggar et al.
Neurology 2005;65:1591-1596.
ABSTRACT | FULL TEXT  

Translational Research on the Way to Effective Therapy for Alzheimer Disease
Rosenberg
Arch Gen Psychiatry 2005;62:1186-1192.
ABSTRACT | FULL TEXT  

Invited Commentary: How Far Can Epidemiologists Get with Statistical Adjustment?
Petitti and Freedman
Am J Epidemiol 2005;162:415-418.
FULL TEXT  

Role of Protein Phosphatases in Estrogen-Mediated Neuroprotection
Yi et al.
J. Neurosci. 2005;25:7191-7198.
ABSTRACT | FULL TEXT  

Update in General Internal Medicine
Sheffield and Larson
ANN INTERN MED 2005;143:212-221.
FULL TEXT  

Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendations from the U.S. Preventive Services Task Force
U.S. Preventive Services Task Force*
ANN INTERN MED 2005;142:855-860.
ABSTRACT | FULL TEXT  

Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial
Yaffe et al.
Am. J. Psychiatry 2005;162:683-690.
ABSTRACT | FULL TEXT  

Estrogen Treatment for Urinary Incontinence: Never, Now, or in the Future?
DuBeau
JAMA 2005;293:998-1001.
FULL TEXT  

17{beta}-Estradiol Differentially Regulates Blood-Brain Barrier Permeability in Young and Aging Female Rats
Bake and Sohrabji
Endocrinology 2004;145:5471-5475.
ABSTRACT | FULL TEXT  

Nuclear Hormone Receptors, Metabolism, and Aging: What Goes Around Comes Around
Pardee et al.
Sci Aging Knowl Environ 2004;2004:re8-re8.
ABSTRACT | FULL TEXT  

Other articles noted
Evid. Based Med. 2004;9:191-192.
FULL TEXT  

23 Apr 2004 to 23 Jul 2004
Evid. Based Nurs. 2004;7:e4-e4.
FULL TEXT  

The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline
Resnick et al.
Clin Trials 2004;1:440-450.
ABSTRACT  

WOMEN'S HEALTH INITIATIVE UPDATE: Estrogen Therapy Does Not Improve Memory or Prevent Dementia
JWatch Women's Health 2004;2004:4-4.
FULL TEXT  

Another Blow for Estrogen Therapy
Journal Watch Cardiology 2004;2004:5-5.
FULL TEXT  

Yet More Bad News About Hormone Therapy, This Time for Cognitive Function
JWatch General 2004;2004:3-3.
FULL TEXT  

Estrogen Replacement Doesn't Lower Dementia Risk
Rosack
Psychiatr. News 2004;39:26-26.
FULL TEXT  

Oestrogen doesn't protect mental function in older women
Tanne
BMJ 2004;328:1514-1514.
FULL TEXT  

Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women: Women's Health Initiative Memory Study
Espeland et al.
JAMA 2004;291:2959-2968.
ABSTRACT | FULL TEXT  

Estrogen and Dementia: Insights From the Women's Health Initiative Memory Study
Schneider
JAMA 2004;291:3005-3007.
FULL TEXT